Led by David Liljenquist, MD, the TrialNet team at Rocky Mountain Diabetes and Osteoporosis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Rocky Mountain Diabetes and Osteoporosis Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Our Team

Portrait Photo

David Liljenquist, MD

Principal Investigator

David Liljenquist, M.D., is board certified in endocrinology/metabolism. He was raised in Idaho Falls and is a graduate of Skyline High School. Dr. Liljenquist attended Brigham Young University, where he received a Bachelor of Science in human biology. After graduating from George Washington University Medical School with distinction, Dr. Liljenquist completed his residency in internal medicine at the Mayo Clinic in Scottsdale, Arizona. He then completed his fellowship training in endocrinology at the University of Chicago. Dr. Liljenquist continues to develop his expertise through additional specialized training courses and through his work in clinical research as a principal or sub investigator. He has shared his expertise and research discoveries through over 30 publications and presentations.

Portrait Photo

Ben Houston, AS, CRC

Clinical Research Coordinator